- Home
- OCTO vs INM Comparison
OCTO vs INM Comparison
Compare OCTO & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCTO
- INM
- Stock Information
- Founded
- OCTO 1966
- INM 1981
- Country
- OCTO United States
- INM Canada
- Employees
- OCTO N/A
- INM N/A
- Industry
- OCTO
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- OCTO
- INM Health Care
- Exchange
- OCTO Nasdaq
- INM Nasdaq
- Market Cap
- OCTO 4.2M
- INM 4.5M
- IPO Year
- OCTO N/A
- INM N/A
- Fundamental
- Price
- OCTO $1.38
- INM $2.22
- Analyst Decision
- OCTO
- INM
- Analyst Count
- OCTO 0
- INM 0
- Target Price
- OCTO N/A
- INM N/A
- AVG Volume (30 Days)
- OCTO 3.4M
- INM 70.4K
- Earning Date
- OCTO 08-26-2025
- INM 09-29-2025
- Dividend Yield
- OCTO N/A
- INM N/A
- EPS Growth
- OCTO N/A
- INM N/A
- EPS
- OCTO N/A
- INM N/A
- Revenue
- OCTO $41,576,562.00
- INM $4,920,990.00
- Revenue This Year
- OCTO N/A
- INM N/A
- Revenue Next Year
- OCTO N/A
- INM N/A
- P/E Ratio
- OCTO N/A
- INM N/A
- Revenue Growth
- OCTO N/A
- INM N/A
- 52 Week Low
- OCTO $0.98
- INM $1.72
- 52 Week High
- OCTO $4.86
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- OCTO 48.32
- INM 35.02
- Support Level
- OCTO $1.52
- INM $2.16
- Resistance Level
- OCTO $1.63
- INM $2.30
- Average True Range (ATR)
- OCTO 0.10
- INM 0.09
- MACD
- OCTO -0.02
- INM 0.01
- Stochastic Oscillator
- OCTO 29.07
- INM 12.31
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.